Example: Heart Attack

Search clinical trials for: AMAG Pharmaceuticals, Inc

Total 52 results

NCT04268849

Not yet recruiting

Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient

Conditions: Iron Deficiency Anemia
NCT04205266

Not yet recruiting

IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding

Conditions: Anemia, Iron Deficiency; Heavy Menstrual Bleeding
NCT04183452

Recruiting

17-OHPC in Pregnancy: IM vs SC Routes

Conditions: Preterm Birth
NCT04179734

Recruiting

Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder

Conditions: Hypoactive Sexual Desire Disorder
NCT03973047

Recruiting

A Study to Evaluate the Rate of Nausea in Healthy Premenopausal Female Subjects Treated With a Single Dose of Bremelanotide Alone or With Zofran

Conditions: Nausea
NCT03893045

Recruiting

A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

Conditions: Iron Deficiency Anemia
NCT03854396

Not yet recruiting

Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women

Conditions: Recurrent Urinary Tract Infection; Postmenopause; Postmenopausal Syndrome; Postmenopausal Symptoms; Menopause
NCT03777514

Withdrawn

Intravenous (IV) Versus Oral Iron Treatment of Iron Deficiency Anemia in the Post-operative Bariatric Surgical Patient

Conditions: IDA in the Post-bariatric Surgical Patient
NCT03740945

Withdrawn

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer

Conditions: Vaginal Atrophy in Breast Cancer Patients
NCT03657433

Recruiting

Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy

Conditions: Iron Deficiency Anemia of Pregnancy
NCT03619850

Recruiting

A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

Conditions: Chronic Kidney Disease; Iron Deficiency Anemia
NCT03619005

Withdrawn

Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study

Conditions: Hypoactive Sexual Desire Disorder (HSDD)
NCT03296982

Completed

Variability of Whole Blood Clotting Time Measurements in Ex Vivo Human Blood Samples Spiked With Anticoagulants

Conditions: Healthy
NCT03297216

Active, not recruiting

Improving Pregnancy Outcomes With Progesterone

Conditions: Pre-term Birth; HIV-1-infection
NCT03288454

Recruiting

Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCT

Conditions: Healthy
NCT03225885

Completed

Counseling for Prematurity Using a Multimedia Education Tool

Conditions: Premature Birth; Counseling; Decision Making; Prenatal Care; Infant, Premature; Resuscitation
NCT03172910

Recruiting

Study of Ciraparantag Administered to Volunteers Anticoagulated With Rivaroxaban, Measure Clotting Times Using WBCT

Conditions: Healthy
NCT03084523

Enrolling by invitation

Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI

Conditions: Stroke; Intracranial Aneurysm; Intracranial Atherosclerosis
NCT03008616

Recruiting

Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclampsia

Conditions: Severe Preeclampsia
NCT02940522

Completed

Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women

Conditions: Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women
NCT02937766

Terminated

Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal Women

Conditions: Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) in Healthy Post-menopausal Women
NCT02694978

Completed

A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

Conditions: Iron Deficiency Anemia
NCT02689401

Withdrawn

MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer

Conditions: Esophageal Cancer
NCT02499354

Recruiting

Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)

Conditions: Restless Legs Syndrome; Iron Deficiency Anemia
NCT02207205

Completed

Variability in the Measurement of WBCT Between Blood Drawn From Indwelling Catheters and Direct Venipuncture

Conditions: Healthy
NCT02207257

Completed

Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With Edoxaban

Conditions: Anticoagulation Reversal
NCT02205905

Completed

An Open-label, Single-dose, Non-randomized Study of IV 14C-labeled PER977 in Healthy Male Subjects

Conditions: Healthy
NCT02206087

Completed

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following Heparin

Conditions: Healthy
NCT02206100

Completed

PK and PD of Single, Escalating Doses of PER977 Following Enoxaparin

Conditions: Healthy
NCT02206568

Withdrawn

Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus
NCT02205827

Completed

A Study to Determine the Inter/Intra Observer and Intra-subject Variability of Whole Blood Clotting Time Measurements

Conditions: Healthy
NCT02189889

Terminated

Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery

Conditions: Anemia; Cardiovascular Disease
NCT01826266

Completed

Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban

Conditions: Anticoagulant Reversal; Reversal of Edoxaban Induced Anticoagulation
NCT01374919

Completed

Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia

Conditions: Iron Deficiency Anemia
NCT01264679

Terminated

A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease

Conditions: Iron Deficiency Anemia
NCT01227616

Completed

A Phase IV Trial of Repeated Doses of Ferumoxytol Compared to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Patients With Chronic Kidney Disease on Hemodialysis

Conditions: The Treatment of Iron Deficiency Anemia in Patients With Chronic Kidney Disease
NCT01155375

Terminated

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease

Conditions: Iron Deficiency Anemia
NCT01155388

Terminated

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease

Conditions: Iron Deficiency Anemia; Nondialysis-dependent Chronic Kidney Disease
NCT01146990

Recruiting

A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth

Conditions: Children Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy Trial
NCT01114204

Completed

A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia

Conditions: Iron Deficiency Anemia
NCT01114217

Completed

A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

Conditions: Iron Deficiency Anemia
NCT01114139

Completed

A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia

Conditions: Iron Deficiency Anemia
NCT01052779

Completed

A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease

Conditions: Iron Deficiency; Anemia; Kidney Disease
NCT01004029

Completed

Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery

Conditions: Preterm Birth
NCT00769093

Terminated

Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy

Conditions: Brain Neoplasms
NCT00707876

Active, not recruiting

Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)

Conditions: Peripheral Arterial Disease (PAD)
NCT00585936

Completed

Imaging Inflammation in Autoimmune Diabetes

Conditions: Diabetes Mellitus, Type 1
NCT00360425

Completed

A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and Women

Conditions: Anemia
NCT00255424

Completed

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

Conditions: Anemia
NCT00255437

Completed

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

Conditions: Anemia